Gilead Sciences, Inc. (GILD) Ownership
GILD ownership summary
as of October 18, 2026- Institutions
- 92.1% of shares outstanding
- Insiders
- 0.11% of shares outstanding
- Shares outstanding
- 1.24B
- Float
- 1.24B shares available to trade
- Short interest
- 1.76% 21.8M shares short
- Days to cover
- 3.70 short interest up 19.3% vs prior month
- Institutions 92.07%
- Insiders 0.11%
- Other investors 7.82%
GILD top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 9.83% | 121.8M | $19.03B | +2.8M (+2.4%) | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 6.54% | 81.1M | $12.67B | +436,958 (+0.5%) | June 30, 2026 |
| 3 | FMR Inc | 5.39% | 66.9M | $10.44B | −5.0M (−7.0%) | June 30, 2026 |
| 4 | State Street Corp | 4.94% | 61.2M | $9.56B | +1.4M (+2.3%) | June 30, 2026 |
| 5 | Capital World Investors | 3.31% | 41.0M | $6.40B | −294,958 (−0.7%) | June 30, 2026 |
| 6 | Amvescap Plc. | 3.21% | 39.8M | $6.22B | −1.8M (−4.2%) | June 30, 2026 |
| 7 | Vanguard Portfolio Management, LLC | 2.85% | 35.3M | $5.52B | +186,703 (+0.5%) | June 30, 2026 |
| 8 | Geode Capital Management, LLC | 2.42% | 30.1M | $4.70B | +339,590 (+1.1%) | June 30, 2026 |
| 9 | T. Rowe Price Associates, Inc. | 2.42% | 30.0M | $4.69B | +3.7M (+14.3%) | June 30, 2026 |
| 10 | Morgan Stanley - Brokerage Accounts | 1.94% | 24.0M | $3.75B | +705,059 (+3.0%) | June 30, 2026 |
| 11 | Dodge & Cox | 1.91% | 23.7M | $3.70B | −573,259 (−2.4%) | June 30, 2026 |
| 12 | NORGES BANK | 1.77% | 22.0M | $3.43B | +642,823 (+3.0%) | June 30, 2026 |
| 13 | JPMorgan Chase & Co | 1.68% | 20.8M | $3.25B | −13.2M (−38.7%) | June 30, 2026 |
| 14 | Capital Research Global Investors | 1.56% | 19.4M | $3.03B | −7.7M (−28.5%) | June 30, 2026 |
| 15 | Bank of America Corp | 1.50% | 18.6M | $2.91B | −1.3M (−6.7%) | June 30, 2026 |
| 16 | Bank of New York Mellon Corp | 1.23% | 15.3M | $2.39B | +210,778 (+1.4%) | June 30, 2026 |
| 17 | Northern Trust Corp | 1.12% | 13.8M | $2.16B | +7,631 (+0.1%) | June 30, 2026 |
| 18 | UBS Asset Mgmt Americas Inc | 1.05% | 13.0M | $2.03B | −212,512 (−1.6%) | June 30, 2026 |
| 19 | Wellington Management Company LLP | 1.02% | 12.7M | $1.98B | −838,308 (−6.2%) | June 30, 2026 |
| 20 | The Goldman Sachs Group Inc | 0.87% | 10.8M | $1.68B | −286,920 (−2.6%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 10.5M shares and 10 cut 31.2M.
GILD top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 3.18% | 39.5M | $6.16B | −74,116 (−0.2%) | August 31, 2026 |
| 2 | Vanguard 500 Index Investor | 2.63% | 32.6M | $5.09B | −419,971 (−1.3%) | September 30, 2026 |
| 3 | Invesco QQQ Trust | 2.09% | 25.9M | $4.05B | −42,240 (−0.2%) | September 30, 2026 |
| 4 | Dodge & Cox Stock I | 1.39% | 17.3M | $2.70B | −810,500 (−4.5%) | June 30, 2026 |
| 5 | iShares Core S&P 500 ETF | 1.33% | 16.5M | $2.58B | −26,603 (−0.2%) | September 30, 2026 |
| 6 | Fidelity 500 Index | 1.30% | 16.1M | $2.52B | +61,899 (+0.4%) | August 31, 2026 |
| 7 | American Funds Income Fd of Amer A | 1.25% | 15.5M | $2.42B | — | September 30, 2026 |
| 8 | State Street® SPDR® S&P 500® ETF | 1.23% | 15.2M | $2.37B | — | September 30, 2026 |
| 9 | Vanguard MStar Value Index Investor | 0.95% | 11.8M | $1.84B | −56,170 (−0.5%) | September 30, 2026 |
| 10 | American Funds Washington Mutual A | 0.91% | 11.2M | $1.76B | −663,880 (−5.6%) | September 30, 2026 |
| 11 | American Funds Capital Inc Bldr A | 0.76% | 9.4M | $1.47B | +2.9M (+44.0%) | September 30, 2026 |
| 12 | State Street®HlthCrSelSectSPDR®ETF | 0.71% | 8.8M | $1.37B | +27,360 (+0.3%) | September 30, 2026 |
| 13 | Vanguard Dividend Appreciation ETF | 0.57% | 7.0M | $1.10B | −12,843 (−0.2%) | September 30, 2026 |
| 14 | Fidelity Contrafund | 0.54% | 6.7M | $1.05B | −2.1M (−24.1%) | August 31, 2026 |
| 15 | JPMorgan Large Cap Growth I | 0.53% | 6.6M | $1.03B | — | August 31, 2026 |
| 16 | Vanguard Institutional Index I | 0.53% | 6.6M | $1.02B | −78,038 (−1.2%) | September 30, 2026 |
| 17 | American Funds American Balanced A | 0.51% | 6.4M | $993.8M | −3.3M (−34.0%) | September 30, 2026 |
| 18 | Vanguard Equity-Income Inv | 0.49% | 6.1M | $957.6M | +50,887 (+0.8%) | June 30, 2026 |
| 19 | iShares Biotechnology ETF | 0.49% | 6.0M | $941.4M | −45,656 (−0.8%) | September 30, 2026 |
| 20 | American Funds Cptl Wld Gr&Inc A | 0.47% | 5.9M | $917.8M | +1.9M (+48.8%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
GILD insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-15 | Andrew D Dickinson | Sell | $140.96 | 3,000 | $422,880 |
| 2026-04-15 | Johanna Mercier | Sell | $140.96 | 3,000 | $422,880 |
| 2026-03-16 | Andrew D Dickinson | Sell | $144.23 | 3,000 | $432,690 |
| 2026-03-16 | Johanna Mercier | Sell | $144.23 | 3,000 | $432,690 |
| 2026-02-27 | Daniel Patrick O'day | Sell | $144.79 | 10,000 | $1.4M |
| 2026-02-17 | Andrew D Dickinson | Sell | $154.43 | 3,000 | $463,290 |
| 2026-02-17 | Johanna Mercier | Sell | $154.44 | 28,000 | $4.3M |
| 2026-02-05 | Daniel Patrick O'day | Sell | $150.00 | 115,640 | $17.3M |
| 2026-01-29 | Ro Khanna | Buy | $139.55 | — | — |
| 2026-01-28 | Daniel Patrick O'day | Sell | $139.89 | 10,000 | $1.4M |
| 2026-01-27 | Josh Gottheimer | Buy | $140.97 | — | — |
| 2026-01-23 | Daniel Patrick O'day | Sell | $135.00 | 115,640 | $15.6M |
| 2026-01-20 | Jeffrey Bluestone | Sell | $123.50 | 5,000 | $617,500 |
| 2026-01-15 | Andrew D Dickinson | Sell | $124.31 | 3,000 | $372,930 |
| 2026-01-15 | Johanna Mercier | Sell | $124.31 | 3,000 | $372,930 |
| 2025-12-29 | Daniel Patrick O'day | Sell | $124.83 | 10,000 | $1.2M |
| 2025-12-15 | Johanna Mercier | Sell | $122.00 | 3,000 | $366,000 |
| 2025-12-15 | Andrew D Dickinson | Sell | $122.00 | 3,000 | $366,000 |
| 2025-11-28 | Jeffrey Bluestone | Sell | $125.08 | 5,000 | $625,400 |
| 2025-11-28 | Kelly A Kramer | Sell | $127.10 | 2,805 | $356,516 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
GILD shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns GILD
Institutional investors own 92.1% of Gilead's shares and insiders 0.11%. The largest holder is BlackRock Inc with 9.83% of the shares (121.8M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 10 reduced their stake in the latest filings. Short interest is 1.76% of the float, or 3.70 days of average trading volume. The share count fell 21.5% since 2014.
Related: GILD analyst forecast, GILD key metrics, GILD dividend history. See the GILD stock overview for the latest quote and news.
GILD ownership FAQ
Who owns the most Gilead stock?
The largest shareholders of Gilead are BlackRock Inc (9.83%), Vanguard Capital Management, LLC (6.54%), FMR Inc (5.39%), State Street Corp (4.94%), Capital World Investors (3.31%).
What percentage of Gilead is owned by institutions?
Institutions hold 92.1% of Gilead's shares outstanding; insiders hold 0.11%.
Which funds own Gilead?
The largest fund holders of Gilead are Vanguard MStar Total Stk Mkt Idx Invest (3.18%), Vanguard 500 Index Investor (2.63%), Invesco QQQ Trust (2.09%), Dodge & Cox Stock I (1.39%), iShares Core S&P 500 ETF (1.33%).
What is Gilead's short interest?
21.8M shares of Gilead were sold short, 1.76% of the float; at the average daily volume it would take 3.70 days to cover.
Are insiders buying or selling Gilead?
Of the latest 20 reported insider transactions in Gilead (since November 28, 2025), 2 were purchases and 18 were sales.
How many shares of Gilead are outstanding?
Gilead has 1.24B shares outstanding, of which 1.24B are in the public float.